Illinois Tool Works Inc. Q4 FY2025 earnings call

Management Statement and Operational Highlights

• Fourth Quarter: Outperformed end markets with revenue growth >4% and GAAP EPS up 7% to $2.72; operating income $1.1 billion, up 5%; segment margins 27.7%, 120 basis points with 140 basis points from enterprise initiatives. Q4 demand improved with 4% sequential growth from Q3.
• 2025 Performance: Consistently outperformed markets, improved profitability, and made progress on strategic priorities; achieved 2.4% CBI-fueled revenue growth, a 40 basis point improvement toward 2030 goal of 3%+; patent filings increased 9% in 2025 following an 18% increase in 2024.
• 2026 Guidance: Organic growth projection 1%-3%; GAAP EPS range $11-$11.20 (midpoint $11.20, 7% growth); operating margin expected to improve ~100 basis points to 26.5%-27.5% from enterprise initiatives; first half/second half EPS split ~47/53%, Q1 EPS ~23% of full-year; plan to buy back ~$1.5 billion of shares and free cash flow conversion to net income >100%.

Segment Performance

• Automotive OEM: Q4 revenue increased 6% with organic revenue up 2%; regionally, North America up 2%, Europe down 1%, China up 5%. Full-year 2025 outperformed relevant builds, expecting 200-300 basis points of outperformance in 2026; full-year margins improved 150 basis points to 21.1% in 2025, with further expansion expected in 2026.
• Food Equipment: Q4 revenue growth 4% with organic growth 1% (equipment flat, service up 3%); regionally, North America flat, institutional end markets up high single digits, restaurants down high single digits, retail up nearly 5%, international up 2%; operating margins improved 110 basis points to 28.1%.
• Test and Measurement and Electronics: Q4 revenue up 6% with organic revenue up 2% (test and measurement up 3%, electronics flat); saw positive pickup in semiconductor and electronics activity, semi-related businesses up mid-single digits; operating margins improved 110 basis points to 28.1%.
• Welding: Q4 revenue grew 3% with organic growth 2% (equipment up 4%, consumables flat, filler metals up high single digits); regionally, North America up 4%, international down 5%; operating margin reached 33.3%, a 210 basis points improvement.
• Polymers and Fluids: Q4 organic growth 5% supported by new product launches; automotive aftermarket up 5%, polymers up 4%, fluids up 6%; regionally, North America up 5%, international up 4%; operating margin expanded 110 basis points to 29%.
• Construction Products: Q4 organic growth down 4% (North America down 4%, residential renovation down 5%, commercial construction up 5%; Europe down 5%, Australia and New Zealand flat); despite top-line challenge, margins expanded 100 basis points to 29%.
• Specialty Products: Q4 revenue increased 4% with organic revenue up 1% (equipment up 12%, consumables down 2%); regionally, North America flat, international up 3%.

Guidance

• Total revenue projection: 2%-4%.
• Organic growth projection: 1%-3%.
• GAAP EPS range: $11-$11.20, midpoint $11.20 (7% growth).
• Operating margin expected to improve ~100 basis points to 26.5%-27.5% due to enterprise initiatives.
• Plan to repurchase approximately $1.5 billion of shares in 2026; free cash flow conversion to net income expected to be >100%.

Risks

• Refer to the company's 2024 Form 10-Ks and subsequent reports filed with the SEC for important risks that could cause actual results to differ materially from expectations.

Question and Answer

Q: Andrew Kaplowitz from Citigroup asked about test and measurement improvement and margin expansion.

A: Christopher O'Herlihy responded that test and measurement had a solid quarter with improvement in bookings and semi-related activity, and margin expansion driven by enterprise initiatives and CBI.

Q: Joseph Ritchie from Goldman Sachs inquired about price-cost dynamics and resin costs.

A: Christopher O'Herlihy stated price-cost is slightly favorable in 2026 but not a big margin driver, and resin costs are not material to overall performance.

Q: Julian Mitchell from Barclays asked about seasonality and CBI progress.

A: Christopher O'Herlihy discussed typical seasonality and CBI progress with 2.4% CBI-fueled revenue growth in 2025 and continued progress toward 2030 goals.

Q: Scott Davis from Melius Research asked about M&A and CBI.

A: Christopher O'Herlihy mentioned M&A is on the table for the right opportunities and CBI progress with patent filings and incentive plans aligned with CBI goals.

Q: Tami Zakaria from JPMorgan asked about growth in China and Americas vs Europe.

A: Christopher O'Herlihy discussed strong growth in China auto OEM due to EV penetration and organic growth expectations for North America, Asia Pacific, and Europe.

Q: Jamie Cook from Truist Securities asked about sequential revenue growth and incremental margins.

A: Christopher O'Herlihy noted sequential growth was broad-based and incremental margins in mid to high 40s due to portfolio quality and CBI contributions.

Q: Steven Fisher from UBS asked about enterprise initiatives and margins.

A: Christopher O'Herlihy explained margin improvement from enterprise initiatives offset by some costs, with expectations for continued margin expansion.

Q: Sabrina Abrams from Bank of America asked about FX tailwind and polymers/fluids performance.

A: Christopher O'Herlihy discussed FX tailwind impact and polymers/fluids growth driven by CBI new products.

Q: David Rasa from Evercore asked about January organic performance and inventory.

A: Christopher O'Herlihy stated January is on track, organic growth is cyclical with seasonality, and inventory levels are normal.